Background Acute kidney injury (AKI) can be caused by multiple factors/events, including
acute coronary syndrome (ACS). Ceramides are involved in atherosclerosis progression …

Aim Plasma levels of certain ceramides are increased in patients with ischemic heart
disease (IHD). Many risk factors for IHD are also risk factors for chronic kidney disease …

Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …

Abstract Background Plasma ceramides (Cer) have been used to evaluate risk of
cardiovascular (CV) events in patients with coronary heart disease. We investigated the …

Abstract Aims Ceramide (Cer) and phosphatidylcholine (PC) lipids are associated with
pathophysiological processes in cardiovascular (CV) diseases. A previously derived and …

Background and aims The relationship between ceramides and the risk of mortality among
patients with coronary artery disease (CAD) is currently relatively sparse. This prospective …

Abstract Background Plasma ceramides (Cer), a subset of bioactive lipids, have mechanistic
links to atherosclerotic coronary artery disease (CAD) pathogenesis and are related to major …

Circulating ceramide levels are dysregulated in kidney disease. However, their associations
with rapid decline in kidney function (RDKF) and end-stage kidney disease (ESKD) in …

Objective—Ceramides are sphingolipids involved with cellular signaling. Synthesis of
ceramides occurs in all tissues. Ceramides accumulate within tissues and the blood plasma …

Ceramides have been associated with cardiometabolic disease (eg, acute myocardial
infarction (AMI) and type 2 diabetes (T2D)) and adverse outcomes. Acute admission …